CV Sciences, Inc. specializes in the development, manufacture, and distribution of nutraceuticals and plant-based foods, with a focus on hemp extracts and other natural ingredients. The company operates in the consumer wellness industry, catering to both business-to-business (B2B) and business-to-consumer (B2C) markets. CV Sciences generates revenue through the sale of its branded products, which include hemp extracts and plant-based food items. The company's primary products are sold under the brands +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | ZTS | Zoetis Inc. | 52.41 Bn | 19.60 | 5.54 | 9.04 Bn |
| 2 | TEVA | Teva Pharmaceutical Industries Ltd | 35.83 Bn | 25.23 | 2.08 | 16.81 Bn |
| 3 | UTHR | UNITED THERAPEUTICS Corp | 25.40 Bn | 19.03 | 7.98 | - |
| 4 | NBIX | Neurocrine Biosciences Inc | 12.96 Bn | 27.02 | 4.53 | - |
| 5 | HCM | HUTCHMED (China) Ltd | 12.76 Bn | 28.06 | 23.27 | 0.09 Bn |
| 6 | ELAN | Elanco Animal Health Inc | 11.22 Bn | -48.11 | 2.38 | 4.02 Bn |
| 7 | ALKS | Alkermes plc. | 5.52 Bn | 22.80 | 3.74 | - |
| 8 | LNTH | Lantheus Holdings, Inc. | 5.51 Bn | 23.64 | 3.57 | 0.57 Bn |